Aurinia Pharmaceuticals Inc
|Market Cap (Intraday)||670.06M|
|2yr Forward PE||N/A|
Aurinia Pharmaceuticals Inc Stock, NASDAQ:AUPH
Aurinia Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of a therapeutic drug to treat autoimmune diseases. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.